| Up
2006P-0351:
Restriction or Withdrawal of the Use of Angiotensin Converting Enzyme
Inhibitor (ACEI) and Angiotensin Receptor Blocker (ARB) Therapy
in the Following Conditions
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Document #
|
| Received Date
|
| Filed
Date
|
| Submitter Code
|
| Submitter
|
| FR
Date
|
| FR
Page
|
| Comment Date
|
| Files
|
| Remarks
|
|
|
|
|
|
| |
ACK1 |
|
09/06/2006
|
|
09/06/2006
|
|
Federal Government |
|
FDA/DDM Diplomate
of the American Board of Internal Medicine & Nephrology
Fulbright Scholar in Medi |
|
|
|
|
|
|
|
pdf |
|
|
|
| |
Signature: |
|
Jennie C. Butler
|
|
|
| |
CP1 |
|
09/06/2006
|
|
09/06/2006
|
|
Academia
|
|
Diplomate of
the American Board of Internal Medicine & Nephrology Fulbright
Scholar in Medicine |
|
|
|
|
|
|
|
pdf
Attachment
|
|
|
|
| |
Signature: |
|
Anil K. Mandal |
|
Top | Up
Page last updated
October 10, 2006
kk
Dockets Home Page | Dockets
Contacts and Location | Operating
Status | Item
Code Definitions | Federal
Register
FDA Home Page | Search
FDA Site | FDA A-Z Index
| Contact FDA
FDA/Dockets Management |
